As a potential biomarker of treatment response, ctDNA and utDNA analyses were performed before systemic therapy, at restaging, and for responders at the beginning of adjuvant nivolumab. ctDNA was ...

At MD Anderson, a study led by a medical researcher and concert pianist shows that surgery patients benefit from prescribed ...

Patients with leptomeningeal metastasis (LM) have historically had few treatment options. Now, researchers from The University of Texas MD Anderson Cancer Center have found a combination of targeted ...

When his beloved dog was given months to live, an Australian man harnessed the power of machine learning and mRNA technology ...

The finding suggests other chemo drugs, too, may be making cancer cells cause a surprising immune-system reaction.

Scientists are working to create "digital twins" of patients that they can test treatments on, in hopes of delivering personalized health care.

On the other side of surgeries and long hospital stays, JJ De La Fuentes rang the bell Monday at UMC surrounded by family and friends.

Spencer Laird was diagnosed with colon cancer at 26. At 30, he was told it had returned and spread to his lungs, with one tumor the size of a golf ball.

In recent years, scientists have discovered that some chemotherapy drugs not only kill cancer cells directly, but at least in some patients, mysteriously also trigger their immune system to attack the ...

NEW ORLEANS - Ochsner MD Anderson Cancer Center will be the first in the South to offer Biology-Guided Radiotherapy, joining ...

SPRING, Texas, March 11, 2026 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc. in Spring, Texas, announces collaborative publication of data from preclinical studies with scientists at The University of ...